Jared Holz, Mizuho Securities healthcare equity strategist, joins 'Squawk Box' to discuss Eli Lilly's announcement to release single-dose vials of its anti-obesity drug Zepbound, how the news will expand access to the drug, state of the obesity drug market, and more.
Jared Holz, Mizuho Securities healthcare equity strategist, joins 'Squawk Box' to discuss Eli Lilly's announcement to release single-dose vials of its anti-obesity drug Zepbound, how the news will expand access to the drug, state of the obesity drug market, and more..
Back to Health Page
